$LEAS Major Pharma Potential with Acquisitions lined up PT .50PHARMIA’s $LEAS goal is to become a leading generics and super-generics company within 5 years. In executing its Plan, PHARMIA will take a three stage approach to the achievement of its goals.
Stage 1
In the initial stage, PHARMIA will launch the company by acquiring MAs in Europe and ANDAs in the